Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.36 |
| ▸ | HTR3B | O95264 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8673923 | 0.88 | CYP3A4 (0.53) | CYP3A4ALDH1A1HPGDTDP1TRPA1 | |
| SCHEMBL10316751 | 0.85 | ALDH1A1 (0.55) | CYP3A4ALDH1A1HPGDTDP1TRPA1 | |
| SCHEMBL3601910 | 0.83 | APLNR (0.42) | CYP3A4ALDH1A1HPGDHTTKDM4E | |
| SCHEMBL30266941 | 0.83 | APLNR (0.42) | CYP3A4ALDH1A1HPGDHTTKDM4E | |
| SCHEMBL8564350 | 0.82 | CYP3A4 (0.43) | CYP3A4ALDH1A1HPGDTDP1TRPA1 | |
| SCHEMBL10341831 | 0.82 | CYP3A4 (0.43) | CYP3A4ALDH1A1HPGDTDP1TRPA1 | |
| SCHEMBL703276 | 0.81 | ALDH1A1 (0.71) | CYP3A4ALDH1A1HPGDTDP1GAA | |
| SCHEMBL29541267 | 0.81 | ALDH1A1 (0.71) | CYP3A4ALDH1A1HPGDTDP1GAA | |
| SCHEMBL10392671 | 0.81 | CYP3A4 (0.42) | CYP3A4ALDH1A1HPGDTDP1TRPA1 | |
| SCHEMBL10341987 | 0.81 | PDIA6 (0.47) | CYP3A4ALDH1A1HPGDTDP1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7211202-B2 | Process to make a conductive composition of a fluorinated polymer which contains polyaniline | ATOFINA (FR) | 2007-05-01 | — | — | US | claimed |
| EP-1428857-B1 | Process to make a conductive composition of a fluorinated polymer which contains polyaniline | ARKEMA FRANCE (FR) | 2007-01-31 | — | — | EP | claimed |
| EP-1377589-B1 | OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2005-09-07 | — | — | EP | claimed |
| US-20240216355-A1 | PHARMACEUTICAL COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF A DISEASE OR DISORDER CAUSED BY OR ASSOCIATED WITH ONE OR MORE PREMATURE TERMINATION CODONS | MONTE ROSA THERAPEUTICS AG (CH) | 2024-07-04 | — | — | US | disclosed |
| EP-4313047-A1 | PHARMACEUTICAL COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF A DISEASE OR DISORDER CAUSED BY OR ASSOCIATED WITH ONE OR MORE PREMATURE TERMINATION CODONS | Monte Rosa Therapeutics, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| US-20220326230-A1 | NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF | FIRMENICH INCORPORATED (US) | 2022-10-13 | — | — | US | disclosed |
| WO-2022200857-A1 | PHARMACEUTICAL COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF A DISEASE OR DISORDER CAUSED BY OR ASSOCIATED WITH ONE OR MORE PREMATURE TERMINATION CODONS | MONTE ROSA THERAPEUTICS AG (CH) | 2022-09-29 | — | — | WO | disclosed |
| EP-4041231-A1 | ISOINDOLINONE COMPOUNDS | Monte Rosa Therapeutics AG (CH) | 2022-08-17 | — | — | EP | disclosed |
| US-20220242846-A1 | ISOINDOLINONE COMPOUNDS | MONTE ROSA THERAPEUTICS AG (CH) | 2022-08-04 | — | — | US | disclosed |
| US-11268952-B2 | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof | FIRMENICH INCORPORATED (US) | 2022-03-08 | — | — | US | disclosed |
| CN-107935944-B | Diaryl urea quinoxaline derivative with anti-tumor activity and synthetic method thereof | 广西师范大学 | 2021-12-21 | — | — | CN | disclosed |
| WO-1998008839-A1 | COMBINATORIAL PROCESS FOR PREPARING SUBSTITUTED THIOPHENE LIBRARIES | ELI LILLY AND COMPANY (US) | 1998-03-05 | — | — | WO | disclosed |
| EP-0821041-A2 | Aqueous coating dispersion, process for the preparation thereof and use thereof in anticorrosive paint | DSM N.V. (NL) | 1998-01-28 | — | — | EP | disclosed |
| EP-0821040-A1 | Aqueous coating dispersion, process for the preparation thereof and use thereof in anticorrosive paint | DSM N.V. (NL) | 1998-01-28 | — | — | EP | disclosed |
| EP-0816309-A1 | Scavenger assisted combinatorial process for preparing libraries of urea and thiourea compounds | ELI LILLY AND COMPANY (US) | 1998-01-07 | — | — | EP | disclosed |
| EP-0538939-B1 | Polymer composition | DSM NV (NL) | 1996-06-19 | — | — | EP | disclosed |
| EP-0589529-A1 | Dispersion of electrically conductive particles in a dispersing medium | DSM N.V. (NL) | 1994-03-30 | — | — | EP | disclosed |
| US-5262483-A | Styrene-maleic anhydride and polyaniline grafted with processability and conductivity | DSM N.V. (NL) | 1993-11-16 | — | — | US | disclosed |
| EP-0538939-A1 | Polymer composition | DSM N.V. (NL) | 1993-04-28 | — | — | EP | disclosed |
| US-3969532-A | 1-Aryl-3-(2-hydroxyethyl) thioureas for treating depression | THE DOW CHEMICAL COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240216355-A1 | PHARMACEUTICAL COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF A DISEASE OR DISORDER CAUSED BY OR ASSOCIATED WITH ONE OR MORE PREMATURE TERMINATION CODONS | UPF1, NSUN2, RTF2 | CYP3A4 3128/4885ALDH1A1 4150/4885HPGD 3614/4885 |
| US-20220326230-A1 | NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF | TAS1R2, TAS1R1, TAS2R30 | CYP3A4 3465/4885ALDH1A1 1089/4885HPGD 1938/4885 |
| US-20220242846-A1 | ISOINDOLINONE COMPOUNDS | AOC2, AOC3, INF2 | CYP3A4 463/4885ALDH1A1 1331/4885HPGD 2148/4885 |
| US-11268952-B2 | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof | TAS2R40, TAS1R2, TAS1R1 | CYP3A4 3085/4885ALDH1A1 1037/4885HPGD 1694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.